The Weill Department of Medicine is focused on increasing its research footprint both at Weill Cornell and on a national level. To that end, the department has established a mentoring infrastructure to assist junior faculty during their transition to NIH K and R series grants. This infrastructure supports a monthly meeting that seeks to build, promote, and mentor the department's junior faculty.
Founded in 1908, the American Society of Clinical Investigation is an honor society of some 3,000 physician-scientists who serve in the upper ranks of academic medicine and industry. Those who become members of ASCI are premier leaders in translating findings from the laboratory to the advancement of clinical practice.
The department announces a new fellowship which is designed to train generalist clinician-scientists for careers in global health research. Over the past decade, there has been a heightened recognition of the need for generalist clinician-scientists in global health, reflecting the rise of non-communicable diseases in resource-limited settings and the importance of primary care for sustainable health improvements.
The paper focuses on solutions aimed at promoting female leaders from both resource-wealthy and -poor countries and highlights challenges such as climbing institutional career ladders, tensions between career and family responsibilities, and health and safety issues. At centers for global health at the top 50 US medical schools, less than a fourth of directors are women. Only one of Tanzania's four regional referral hospitals and one of its five major medical schools have female directors.
Dr. Kyu Rhee and colleagues have uncovered a link between the function of a well-known enzyme and the virulence of the TB bacterium. Their findings are helping to uncover why the TB bacterium is naturally resistant to antibiotic treatment, and they suggest a strategy that could make new and existing drugs more powerful in treating TB. TB is the world's leading bacterial cause of death.
Initiated in 2002, the Fellow Award in Research is presented annually to fellows within the Weill Department of Medicine who have presented outstanding research. This year's finalists were announced at the June 10 Medicine Grand Rounds (12th Annual).
Dr. Henry W. Murray has been working on leishmaniasis, in the laboratory and clinically, for nearly 35 years. For 15 years he carried out clinical treatment trials research in visceral leishmaniasis ("kala-azar") India. The drug he and colleagues in India introduced and tested in the treatment of kala-azar, miltefosine, has been approved by the FDA as the first effective oral agent for leishmaniasis (visceral, cutaneous and mucosal infection).
The project, which focuses on the racial differences in response to antiretroviral therapy for HIV infection, is supported by the NIH-funded ACTG (AIDS Clinical Trials Group). In the field of HIV patient care, racial/ethnic disparities in treatment outcome have been well documented at the local and national level, however the source of this disparity is not well elucidated.
Dr. Jeffrey Laurence, an internationally recognized expert on HIV-AIDS and a Professor of Medicine in the Division of Hematology and Medical Oncology, appeared in an HBO documentary on AIDS.
Dr. Kyu Y. Rhee, Associate Professor of Medicine, Division of Infectious Diseases, and a team of physician-scientists applied the technology of mass spectrometry to study the process by which existing antibiotics attack tuberculosis once inside bacterial cells.
Division Brochure
